Monte Rosa Therapeutics
Monte Rosa Therapeutics is a clinical-stage biotechnology company developing highly selective molecular glue degrader (M
221 employees · est. 2018 · Boston, United States
Ridgeline Discovery
A Versant Ventures Discovery Engine
60 employees · est. 2017 · Basel, Switzerland
Ridgeline Discovery is the older company (2018 vs 2017); Monte Rosa Therapeutics is the larger of the two.
Side-by-Side Comparison
| Metric | Monte Rosa Therapeutics | Ridgeline Discovery |
|---|---|---|
| Founded | ||
| Founded | 2018 | 2017 older |
| Headquarters | ||
| Headquarters | Boston, United States | Basel, Switzerland |
| Employees | ||
| Employees | 221 larger | 60 |
| Industry | ||
| Industry | Biotechnology, Health and Wellness | Biotechnology, IT |
| Funding Stage | ||
| Funding Stage | IPO | Not tracked yet |
| Total Funding | ||
| Total Funding | $570.50M | Not tracked yet |
| Funding Rounds | ||
| Funding Rounds | 9 | Not tracked yet |
| Services | ||
| Services | Discovery and development of molecular glue degraders (MGDs), Research on protein degradation for medical therapeutics, Innovation in AI and structural biology for drug discovery | Not tracked yet |
| Target Customers | ||
| Target Customers | Pharmaceutical companies, Healthcare providers, Medical researchers, Investors in biotechnology | Not tracked yet |
| Taxonomy | ||
| Taxonomy | Clinical-stage, Molecular Glue Degraders, Oncology, Autoimmune Diseases, Inflammatory Diseases, QuEEN Discovery Engine, AI-guided Chemistry, Chemical Libraries, Structural Biology, Proteomics, Protein Degradation, Therapeutic Development, Selective Drug Design, Targeted Therapy | Biotech Company Creation, Drug Discovery, Oncology, Immunology, Small Molecules, Biologics, Gene Therapy, Cell Therapy, International Team, Industry Partnerships, Academic Collaborations, Basel Expansion, Experienced Professionals, Company Operations |
| Website | ||
| Website | monterosatx.com | ridgelinediscovery.com |
About Monte Rosa Therapeutics
Monte Rosa Therapeutics, founded in 2018, is a United States-based clinical-stage biotechnology company at the forefront of developing highly selective molecular glue degrader (MGD) medicines. These innovations target patients with serious conditions across oncology, autoimmune, and inflammatory dis...
About Ridgeline Discovery
Ridgeline Discovery, a Versant Ventures Discovery Engine, is a significant player in the biotechnology and IT industries. Founded in 2017, it has been instrumental in creating and operating innovative biotech companies in partnership with entrepreneurs, industry leaders, and leading academics across...
Be first to know when either one moves
Funding rounds, hiring surges, leadership changes and stack switches at Monte Rosa Therapeutics and Ridgeline Discovery — tracked continuously, sent the day they land.
Funding, hiring, leadership and stack changes at Monte Rosa Therapeutic... and Ridgeline Discovery — by email.
Frequently Asked Questions
Compare Monte Rosa Therapeutics with someone else
Start typing a company name or domain.